Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled Trial

Autor: Nasser, Azmi, Liranso, Tesfaye, Adewole, Toyin, Fry, Nicholas, Hull, Joseph T., Chowdhry, Fatima, Busse, Gregory D., Melyan, Zare, Cutler, Andrew J., Findling, Robert L., Schwabe, Stefan
Zdroj: In Clinical Therapeutics April 2021 43(4):684-700
Databáze: ScienceDirect
Externí odkaz: